Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 April 2019 | Story Ruan Bruwer | Photo Varsity Cup
Vishuis
Vishuis will be trying to win their overall seventh Varsity hostel title on Monday.

Managing his players is of the utmost importance if the University of the Free State’s (UFS) Abraham Fischer Residence (Vishuis) is to claim a fourth straight and seventh overall national hostel title, says Zane Botha, head coach of the hostel team at the UFS.

The Varsity Hostel competition, which will be taking place in Stellenbosch, has been drastically shortened to only three days of rugby because Steinhoff has withdrawn their sponsorship.

If Vishuis makes it to the final, they will play three matches in four days.
They will face the Kovacs of the University of the Western Cape (UWC) on Friday 12 March 2019, followed by the semi-final on Saturday and the final on Monday. The final will take place at 14:00 and will be broadcast live on SuperSport.

“This will be new territory for us. We will have to make good tactical decisions; it won’t be possible for a prop to play for 70 minutes in all three encounters,” said Botha, who is in his third year with the hostel.

The team played three warm-up matches, which they won convincingly. We still have the core of last year’s team, together with some exciting youngsters.
Botha explained that they kept to their strategy of working harder than anyone else on the practice field and during matches. In last year’s final, Vishuis defeated Patria of the North-West University by 55-29, which was the biggest winning margin in the 11 years of the competition. Vishuis walked away with the crown in 2010, 2012, 2013, 2016, 2017, and 2018.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept